Start Time: 09:00 January 1, 0000 9:26 AM ET
Pediatrix Medical Group, Inc. (NYSE:MD)
Q2 2023 Earnings Conference Call
August 03, 2023, 09:00 AM ET
Company Participants
Jim Swift - CEO
Marc Richards - EVP and CFO
Charles Lynch - SVP, Finance and Strategy
Conference Call Participants
Pito Chickering - Deutsche Bank
Brian Tanquilut - Jefferies
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Second Quarter Earnings Conference Call. At this time, your telephone lines are in a listen-only mode. Later, there will be an opportunity for questions and answers, with instructions given at that time. [Operator Instructions]. As a reminder, your call today is being recorded.
I will now turn the conference call over to your host, Charles Lynch. Please go ahead.
Charles Lynch
Thank you, Allen, and good morning, everyone. Welcome to our call. I will quickly read our forward-looking statements before we get into our comments. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by Pediatrix's management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.
Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's most recent annual report on Form 10-K, its quarterly reports on Form 10-Q and its current reports on Form 8-K, including the sections entitled Risk Factors.
In today's remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in this morning's earnings press release, our quarterly reports on Form 10-Q and our annual report on Form 10-K and finally on our website at pediatrix.com.
With that, I'll turn the call over to our CEO, Dr. Jim Swift.
Jim Swift
Thank you, Charlie, and good morning, everyone. Also with me today is Marc Richards, our Chief Financial Officer. Our operating results for the second quarter continue to track very near our expectations. Patient volume trends decelerated somewhat from the first quarter, but remained stable to positive.